White Papers - Applied Clinical Trials

ADVERTISEMENT

To read PDF files you need Adobe Acrobat® Reader.
Click here for your free copy.
White Papers

Inspection Focus in Clinical Trials Using a Risk-Based Monitoring Approach

September 1, 2014

How will clinical trials that adopt an RBM approach be inspected? Covance shares actionable insights to start answering this vitally important question.

Risk-Based Monitoring for Late-Phase Research

September 1, 2014

The growing consensus among clinical researchers and regulatory authorities is that risk-based monitoring (RBM) is more likely to ensure patient protection and overall study quality and allows for monitoring that can be more effective than the traditional model of routine visits to all sites with 100% source data verification (SDV).

Clinical Trials Tools for All Merge eClinical delivers sophisticated technology that benefits any user

August 28, 2014

Advances in information technology are revolutionizing how CROs, sponsors and academic institutions can design and manage clinical studies. The growth of affordable, secure cloud-based software services, mobile communications and the digitization of clinical data is helping researchers worldwide conduct studies more quickly, efficiently and cost-effectively. In short, the impact of an organization’s size, budget or existing technology infrastructure on its ability to conduct or compete for trials is decreasing. This trend will accelerate in the next few years, offering a range of benefits for sites, sponsors and CROs as well as patients and medical professionals. Using the eClinicalOS platform from Merge eClinical as a case study, this podcast explores the development and application of current and emerging technologies in clinical research.

Barnett's July 2014 - January 2015 Course & Publications Catalog

August 15, 2014

Are you a clinical research professional looking for training resources? Barnett's July 2014 - January 2015 Course & Publications Catalog offers a variety of training programs. These programs are designed to maximize learner engagement and include the following: In-Person and Web-Based training courses, custom programs and services, eLearning, and Publications.

Seven Ways to Optimize Inflammation Trials

May 1, 2014

The shift from organ-based symptom relief to mechanism-based treatment and disease modification in immune-mediated inflammatory diseases has generated new challenges. However, the shift also provides the opportunity to reap new benefits. Find out how you can successfully overcome challenges such as placebo response, optimal use of PROs, patient compliance and retention with this whitepaper where two Covance inflammation clinical trial experts share experience-based approaches.

Patient-Centered Innovation in Clinical Trials

May 1, 2014

The paper features executive insights and best practices from leading innovators on how to implement patient-centricity in clinical trials. It also includes practical steps to boost patient engagement with the existing site-centric model and beyond, as well as a guide on how to place data generation in the patients’ hands.

Integrating Disparate Data for Better Treatment Decisions in Oncology

April 18, 2014

Cancer is one of the leading causes of death and healthcare cost worldwide. As such, it has been and will continue to be an area of focus for pharmaceutical companies, healthcare providers, payer and reimbursement organizations, regulatory bodies, and other policymakers. The data being generated across all these domains has already resulted in enormous demands for intelligent ways to store and analyze information in a timely, geographically dispersed, and cost- effective manner. Here, we discuss perspectives on strategies for managing information in the critical therapeutic area of cancer.

Monitoring Blood Pressure in Clinical Trials

April 14, 2014

Dr. Philip Sager, consultant for Biomedical Systems, explores several related topics to discuss the impact of medicines on Blood Pressure (BP), and the role BP plays in the development and testing of compounds. This whitepaper explains challenges of using epidemiologic data for risk assessment; the cardiovascular risk from BP changes with long-term therapy; the precision of measurement techniques; developing an assessment process from nonclinical evaluation through Phase III monitoring; mitigating risk; and the use of ambulatory BP monitoring (ABPM) in clinical trials.

Cutting Costs, Saving Time: Improving Life Sciences Operations with Digital Signatures

April 1, 2014

More than 20,000 FDA-regulated organizations, including 9 of the top 10 Pharmas and 7 of the top 10 CROs, are already using CoSign digital signatures in order to streamline operations, improve collaboration, support compliance and lower costs. In this whitepaper, you’ll get an inside look at how ten real-world life sciences organizations are using digital signatures to gain these benefits and more. You’ll also get a checklist of what to look for when evaluating a digital signature solution for your organization.

ADVERTISEMENT

ADVERTISEMENT

Untitled Document
Click here